Efficacy of Mirtazapine on Irritable Bowel Syndrome with Anxiety and Depression: A Case Study.
Efficacy of Mirtazapine on Irritable Bowel Syndrome with Anxiety and Depression: A Case Study.
J Nippon Med Sch. 2018;85(6):330-333
Authors: Akama F, Mikami K, Watanabe N, Kimoto K, Yamamoto K, Matsumoto H
Abstract
Irritable bowel syndrome (IBS) is a disease in which gastrointestinal symptoms-primarily abdominal pain or discomfort and abnormal bowel movements persist chronically. For patients with IBS, mental illness, especially depression and/or anxiety, leads to a further lower quality of life. The purpose of this case study was to investigate the effects of mirtazapine (MIR) on mental health and IBS symptoms in a case of IBS accompanied by anxiety and a depressive state. This case report suggests that MIR is efficacious for the treatment of IBS with predominant diarrhea accompanied by depression and anxiety.
PMID: 30568059 [PubMed - in process]
Source: Journal of Nippon Medical School - Category: Universities & Medical Training Authors: Akama F, Mikami K, Watanabe N, Kimoto K, Yamamoto K, Matsumoto H Tags: J Nippon Med Sch Source Type: research
More News: Anxiety | Depression | Gastroenterology | Irritable Bowel Syndrome | Men | Mirtazapine | Pain | Study